A multilevel ensemble model for predicting mutation types in bladder cancer [0.03%]
一种预测膀胱癌突变类型的多级ensembl模型
Aneesh Jain,Sumit Dey,Divisha Garg et al.
Aneesh Jain et al.
Background: In urinary bladder cancer, early diagnosis plays a key role for effective patient management. Moreover, accurate prediction of genetic mutations plays a critical role in identifying biomarkers for prognosis an...
MYC variant at 8q24 increases susceptibility to urinary bladder cancer: a meta-analysis of 53,957 individuals [0.03%]
8q24处的MYC变异通过 meta分析发现其增加了53957名个体患膀胱癌的风险
Francisco Cezar Aquino de Moraes,Luis Henrique Rios Moreira Rego,Victória Morbach et al.
Francisco Cezar Aquino de Moraes et al.
Background: Urinary bladder cancer (UBC), the tenth most common globally with a male predominance, has its risk factors like smoking and single nucleotide polymorphisms (SNPs), yet the MYC gene's role, especially the rs96...
Correction [0.03%]
改正通知书
Published Erratum
Personalized medicine. 2025 Nov 18:1. DOI:10.1080/17410541.2025.2589677 2025
Polygenic risk scores to refine Breast cancer screening and prevention strategies [0.03%]
多基因风险评分在乳腺癌筛查和预防策略中的应用
E Roberts,N Flaum,S J Howell et al.
E Roberts et al.
Breast cancer (BC) is the world's most prevalent cancer and can affect almost any post-pubertal woman. Early detection is associated with improved survival, and most high-income countries have adopted population-based screening programs to ...
Leveraging oncology clinical case report data through the Cancer Knowledgebase (CKB) [0.03%]
通过癌症知识库(CKB)利用肿瘤临床病例报告数据
Rewatee H Gokhale,Cara M Statz,Taofei Yin et al.
Rewatee H Gokhale et al.
Aims: Clinical case reports in oncology are an untapped resource of patient data that include relationships between molecular alterations, tumor types, and response to targeted therapy. A current challenge to widespread u...
Patient-Derived Tumour Organoids (PDOs) may help oncologists in clinical practice [0.03%]
患者来源的肿瘤类器官(PDOs)可能有助于临床实践中的肿瘤学家
Renata Brandi,Alina Catalina Palcau,Emilia Migliano et al.
Renata Brandi et al.
The use of cancer organoids represents a major advancement in oncology research, addressing the limitations of traditional 2D cell cultures. Optimized protocols now allow the generation of organoids from a wide range of tumor types, includi...
Association of miR-21 rs1292037 polymorphism with congenital heart disease susceptibility in Chinese children [0.03%]
miR-21 rs1292037多态性与中国儿童先天性心脏病易感性的关联分析
Hongjuan Tang,Wenjuan Zhang,Dan Xu et al.
Hongjuan Tang et al.
Background: Congenital heart disease (CHD) is a condition characterized by structural or functional abnormalities of the cardiovascular system present at birth. This study investigated the correlation between microRNA-21 ...
Tailoring pediatric vancomycin doses: achieving therapeutic levels and minimizing toxicity in oncology patients [0.03%]
儿科万古霉素剂量的调整：在肿瘤患者中达到治疗水平并最小化毒性
Nadeen Hossam,Dalia Makhlouf,Ahmed Elzeiny et al.
Nadeen Hossam et al.
Background: Vancomycin is a widely used nephrotoxic drug in pediatric oncology. Our aim was to assess the initial vancomycin dosing protocols required for achieving the target therapeutic concentrations of vancomycin betw...
Ready to test your DNA?: Public acceptance of genetic testing in the precision medicine era among Chinese residents [0.03%]
精准医疗时代我国居民基因检测的公众接受度调查：你准备好了吗？
Cong Pang,Qun Wang,Zhongxin Su et al.
Cong Pang et al.
Aim: This study aimed to explore the Chinese public's experiences with, perceptions of, attitudes toward, and willingness to use genetic testing (GT) in the precision medicine era. ...
Leveraging circulating microRNAs for personalized disease-modifying therapies in type 1 diabetes [0.03%]
利用循环microRNA进行1型糖尿病的个性化疾病修饰治疗
Giuseppina Emanuela Grieco,Francesco Dotta,Guido Sebastiani
Giuseppina Emanuela Grieco
Type 1 Diabetes (T1D) is a chronic autoimmune disease marked by the progressive immune-mediated destruction of insulin-producing pancreatic beta-cells. The clinical management of T1D is complicated by its heterogeneity and the variability i...